Literature DB >> 9519497

Maternal cannabis use and birth weight: a meta-analysis.

D R English1, G K Hulse, E Milne, C D Holman, C I Bower.   

Abstract

AIMS: To estimate the effect of maternal cannabis use on birth weight.
DESIGN: Meta-analysis of published observational studies adjusted for cigarette smoking. Separate analyses were performed for studies of low birth weight and mean birth weight. We used fixed and random effects models, but in all cases the results were identical.
SETTING: From the Medline database, we identified 10 studies in which the results were adjusted for cigarette smoking. In seven studies, information on cannabis use was collected prenatally. Five studies reported results for differences in mean birth weight associated with maternal cannabis use. PARTICIPANTS: 32,483 women giving birth to live-born infants. MEASUREMENTS: Mean birth weight and odds ratio for low birth weight.
FINDINGS: Three analyses of the studies on mean birth weight were conducted to avoid double-counting women from one study. The largest reduction in mean birth weight for any cannabis use during pregnancy was 48 g (95% confidence interval (CI) 83-14 g), with considerable heterogeneity among the five studies. Mean birth weight was increased by 62 g (95% CI 8 g reduction-132 g increase; p heterogeneity 0.59) among infrequent users (< or = weekly) whereas cannabis use at least four times per week had a 131 g reduction in mean birth weight (95% CI 52-209 g reduction; p heterogeneity 0.25). From the five studies of low birth weight, the pooled odds ratio for any use was 1.09 (95% CI 0.94-1.27, p heterogeneity 0.19).
CONCLUSIONS: There is inadequate evidence that cannabis, at the amount typically consumed by pregnant women, causes low birth weight.

Entities:  

Mesh:

Year:  1997        PMID: 9519497

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  31 in total

1.  Association between marijuana use and adverse obstetrical and neonatal outcomes.

Authors:  C R Warshak; J Regan; B Moore; K Magner; S Kritzer; J Van Hook
Journal:  J Perinatol       Date:  2015-09-24       Impact factor: 2.521

2.  Prevalence and associated birth outcomes of co-use of Cannabis and tobacco cigarettes during pregnancy.

Authors:  Victoria H Coleman-Cowger; Emmanuel A Oga; Erica N Peters; Katrina Mark
Journal:  Neurotoxicol Teratol       Date:  2018-06-05       Impact factor: 3.763

3.  The adverse health effects and harms related to marijuana use: an overview review.

Authors:  K Ally Memedovich; Laura E Dowsett; Eldon Spackman; Tom Noseworthy; Fiona Clement
Journal:  CMAJ Open       Date:  2018-08-16

Review 4.  Prenatal substance abuse: short- and long-term effects on the exposed fetus.

Authors:  Marylou Behnke; Vincent C Smith
Journal:  Pediatrics       Date:  2013-02-25       Impact factor: 7.124

5.  Prevalence and correlates of a lifetime cannabis use disorder among pregnant former tobacco smokers.

Authors:  Rebecca L Emery; Melissa P Gregory; Jennifer L Grace; Michele D Levine
Journal:  Addict Behav       Date:  2015-12-15       Impact factor: 3.913

6.  Urinary concentrations of PAH and VOC metabolites in marijuana users.

Authors:  Binnian Wei; K Udeni Alwis; Zheng Li; Lanqing Wang; Liza Valentin-Blasini; Connie S Sosnoff; Yang Xia; Kevin P Conway; Benjamin C Blount
Journal:  Environ Int       Date:  2015-12-12       Impact factor: 9.621

Review 7.  Pediatric Concerns Due to Expanded Cannabis Use: Unintended Consequences of Legalization.

Authors:  George Sam Wang
Journal:  J Med Toxicol       Date:  2016-05-02

Review 8.  Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions.

Authors:  Luca Ferraro; M C Tomasini; S Beggiato; S Gaetani; T Cassano; V Cuomo; S Amoroso; S Tanganelli; T Antonelli
Journal:  J Neural Transm (Vienna)       Date:  2009-05-12       Impact factor: 3.575

Review 9.  Treatment of neonatal abstinence syndrome.

Authors:  K Johnson; C Gerada; A Greenough
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.